EUTM file information

018219675

XINBEZA


March 31, 2020

Trademark Summary

The trademark XINBEZA was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on May 13, 2020, and received two oppositions.

Opposition Proceedings

There are two Oppositions claimed against trademark.

The first opposition filed on August 13, 2020 by Novus International, Inc. on Likelihood of confusion. the opponent was represented by GREAVES BREWSTER LLP and its proceedings were handled in English The second opposition filed on July 27, 2020 by KOLINPHARMA S.P.A. on Likelihood of confusion. the opponent was represented by HOFFMANN EITLE S.R.L. and its proceedings were handled in English

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

Change of name and professional address of the trademark registration was recorded on August 25, 2020.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for human use, excluding enzymes and excluding food and dietetic supplements.
Trademarkers